Search Results - "FUSELLI, J. J"

Unrecognised ventricular dysfunction in COPD by MACCHIA, A, RODRIGUEZ MONCALVO, J. J, ROMERO, M, TOGNONI, G, KLEINERT, M, COMIGNANI, P. D, GIMENO, G, ARAKAKI, D, LAFFAYE, N, FUSELLI, J. J, MASSOLIN, H. P, GAMBARTE, J

“…While both chronic congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD) impose a substantial disease burden and share aetiological…”
Get full text

Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome by Weber, Michael, MD, Bazzino, Oscar, MD, Navarro Estrada, Jose Luis, MD, de Miguel, Raul, Lic, Salzberg, Simon, MD, Fuselli, Juan J., MD, Liebetrau, Christoph, Woelken, Mariella, MD, Moellmann, Helge, MD, Nef, Holger, MD, Hamm, Christian, MD

“…Background In the present study, we aimed to analyze the diagnostic and prognostic potential of a newly developed high-sensitive troponin T assay and compared…”
Get full text

N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission by Weber, Michael, MD, Bazzino, Oscar, MD, Navarro Estrada, Jose L., MD, Fuselli, Juan J., MD, Botto, Fernando, MD, Perez de Arenaza, Diego, MD, Möllmann, Helge, MD, Nef, Holger N., MD, Elsässer, Albrecht, MD, Hamm, Christian W., MD

“…N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T…”
Get full text

Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes by Bazzino, Oscar, Fuselli, Juan J, Botto, Fernando, Perez de Arenaza, Diego, Bahit, Cecilia, Dadone, Jorge

“…Aims We prospectively studied the additive value of N-terminal probrain natriuretic peptide (NT-proBNP) in relation to the Thrombolysis in Myocardial…”
Get full text

First national survey on management strategies in non ST-elevation acute ischaemic syndromes in Argentina. Results of the STRATEG–SIA study by Ferreirós, E.R., Kevorkian, R., Fuselli, J.J., Guetta, J., Boissonnet, C.P., di Toro, D., Cragnolino, R., Masoli, O., Cagide, A., Krauss, J.

“…Aims To assess the management strategies applied in non-ST elevation acute ischaemic syndromes in Argentina, the factors influencing the choice of treatment,…”
Get full text

Edoxaban versus Warfarin in Patients with Atrial Fibrillation by Giugliano, Robert P, Ruff, Christian T, Braunwald, Eugene, Murphy, Sabina A, Wiviott, Stephen D, Halperin, Jonathan L, Waldo, Albert L, Ezekowitz, Michael D, Weitz, Jeffrey I, Špinar, Jindřich, Ruzyllo, Witold, Ruda, Mikhail, Koretsune, Yukihiro, Betcher, Joshua, Shi, Minggao, Grip, Laura T, Patel, Shirali P, Patel, Indravadan, Hanyok, James J, Mercuri, Michele, Antman, Elliott M

“…Edoxaban, an oral factor Xa inhibitor, was noninferior to warfarin in the prevention of stroke or systemic embolism in patients with atrial fibrillation. There…”
Get full text

Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48) by Link, Mark S, Giugliano, Robert P, Ruff, Christian T, Scirica, Benjamin M, Huikuri, Heikke, Oto, Ali, Crompton, Andrea E, Murphy, Sabina A, Lanz, Hans, Mercuri, Michele F, Antman, Elliott M, Braunwald, Eugene

“…BACKGROUND—Whether the pattern of atrial fibrillation (AF) modifies the risk/benefit of anticoagulation is controversial. In ENGAGE AF-TIMI 48 trial (Effective…”
Get full text

Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48) by Rost, Natalia S, Giugliano, Robert P, Ruff, Christian T, Murphy, Sabina A, Crompton, Andrea E, Norden, Andrew D, Silverman, Scott, Singhal, Aneesh B, Nicolau, José C, SomaRaju, Bhupathi, Mercuri, Michele F, Antman, Elliott M, Braunwald, Eugene

“…BACKGROUND AND PURPOSE—Patients with atrial fibrillation and previous ischemic stroke (IS)/transient ischemic attack (TIA) are at high risk of recurrent…”
Get full text

Cardioversion of Atrial Fibrillation in ENGAGE AF‐TIMI 48 by Plitt, Anna, Ezekowitz, Michael D., De Caterina, Raffaele, Nordio, Francesco, Peterson, Nancy, Giugliano, Robert P.

Get full text

Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin: Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 by Giugliano, Robert P, Ruff, Christian T, Rost, Natalia S, Silverman, Scott, Wiviott, Stephen D, Lowe, Cheryl, Deenadayalu, Naveen, Murphy, Sabina A, Grip, Laura T, Betcher, Joshua M, Duggal, Anil, Dave, Jay, Shi, Minggao, Mercuri, Michele, Antman, Elliott M, Braunwald, Eugene

“…BACKGROUND AND PURPOSE—The once-daily oral factor Xa inhibitor, edoxaban, is as effective as warfarin in preventing stroke and systemic embolism while…”
Get full text

Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial by Wang, Kaijun, Li, Haiyan, Kwong, Winghan J., Antman, Elliott M., Ruff, Christian T., Giugliano, Robert P., Cohen, David J., Magnuson, Elizabeth A.

“…Background The impact of different types of extracranial bleeding events on health‐related quality of life and health‐state utility among patients with atrial…”
Get full text

Prognostic value of C-reactive protein in diabetic patients with unstable angina by Guetta, Javier N., Fuselli, Juan J., Boissonnet, Carlos P., Fairman, Enrique, Piombo, Alfredo, Gagliardi, Juan

Get full text

Utility of the aVL lead in the electrocardiographic diagnosis of atrioventricular node re-entrant tachycardia by Di Toro, Darío, Hadid, Claudio, López, Carlos, Fuselli, Juan, Luis, Vidal, Labadet, Carlos

“…Aims Reciprocating atrioventricular tachycardia can be categorized into common slow-fast atrioventricular node re-entrant (AVNRT) and orthodromic…”
Get full text

Low HDL cholesterol is a strong independent risk marker in non-ST segment elevation acute coronary syndromes by Fuselli, Juan J., Guetta, Javier N., Boissonnet, Carlos P., Godia, José, Tattamanzi, Alejandro, Quiroga, Silvia, Torres, Victor

Get full text

Comparative analyses of the prognostic value of novel cardiac markers in patients with non-ST elevation acute coronary syndromes by Bazzino, Oscar, Estrada, JoséL.Navarro, Botto, Fernando, Liprandi, María I.Sosa, Fuselli, Juan J., Santopinto, José, Ahuad, Rodolfo, Nordaby, Roberto, Salszberg, Simón, Prado, Alfredo Hirschson, López, JoséGant, Russo, Mario, Sokn, Fernando, Pérez, Marcelo, Bruno, Carlos

Get full text

Validation of ACC-AHA 2000 guidelines for the risk stratification of patients with non-ST elevation acute coronary syndromes by Bazzino, Oscar, Botto, Fernando, Estrada, JoséL.Navarro, Liprandi, Maria I.Sosa, Fuselli, Juan J., Santopinto, José, Ahuad, Rodolfo, Nordaby, Roberto, Salzsberg, Simón, Prado, Alfredo Hirschson, López, JoséGant, Russo, Mario, Pérez, Marcelo, Bruno, Carlos, De Miguel, Raul

Get full text

Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation by Yusuf, S, Zhao, F, Mehta, S R, Chrolavicius, S, Tognoni, G, Fox, K K

“…Clopidogrel plus aspirin had clinical benefit beyond that of aspirin alone, but there was an increased risk of bleeding. Thrombosis caused by a ruptured or…”
Get full text

Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes by Bazzino, O., Fuselli, J.J., Botto, F., Perez de Arenaza, D., Bahit, C., Dadone, J.

Get full text